AXSOME THERAPEUTICS INCAXSOME THERAPEUTICS INCAXSOME THERAPEUTICS INC

AXSOME THERAPEUTICS INC

No trades
See on Supercharts

Price target

115.320.000.00%
The 17 analysts offering 1 year price forecasts for 19X have a max estimate of — and a min estimate of —.

Analyst rating

Based on 17 analysts giving stock ratings to 19X in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


19X EPS for the last quarter is −1.56 EUR despite the estimation of −1.22 EUR. In the next quarter EPS is expected to reach −1.24 EUR. Track more of AXSOME THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter AXSOME THERAPEUTICS INC revenue is expected to reach ‪88.35 M‬ EUR. Check out AXSOME THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, 19X price target is 115.32 EUR with a max estimate of 165.67 EUR and a min estimate of 92.04 EUR. Check if this forecast comes true in a year, meanwhile watch AXSOME THERAPEUTICS INC stock price chart and keep track of the current situation with 19X news and stock market news.
We've gathered opinions of 17 analysts rating 19X stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.